ACUTE IRITIS ASSOCIATED WITH PRIMARY SJOGRENS-SYNDROME AND HIGH-TITER ANTI-SS-A/RO AND ANTI-SS-B/LA ANTIBODIES - TREATMENT WITH COMBINATION IMMUNOSUPPRESSIVE THERAPY

被引:16
作者
BRIDGES, AJ
BURNS, RP
机构
[1] UNIV MISSOURI,MED CTR,SCH MED,DEPT INTERNAL MED,COLUMBIA,MO 65201
[2] UNIV MISSOURI,MED CTR,SCH MED,DEPT PATHOL,COLUMBIA,MO 65201
[3] UNIV MISSOURI,MED CTR,SCH MED,DEPT OPHTHALMOL,DIV IMMUNOL & RHEUMATOL,COLUMBIA,MO 65201
[4] UNIV MISSOURI,MED CTR,SCH MED,ANTINUCL ANTIBODY LAB,COLUMBIA,MO 65201
来源
ARTHRITIS AND RHEUMATISM | 1992年 / 35卷 / 05期
关键词
D O I
10.1002/art.1780350511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. We describe a patient with primary Sjogren's syndrome who developed severe, acute, anterior uveitis (iritis), an uncommon complication in this setting. Methods. We present the case report of the clinical findings, course, treatment, and resolution of the acute uveitis. Titers of anti-SS-A/Ro and anti-SS-B/La antibodies were assessed (by immunodiffusion), as were fluorescent antinuclear antibodies (on HEp-2 cells) and cryoglobulins. Results. Initial treatment with topical steroids, oral prednisone (20 mg/day), and oral methotrexate was unsuccessful. The iritis resolved after combined treatment with intravenous cyclophosphamide (1,500 mg/month), high-dose prednisone (60 mg/day), and cyclosporine (5 mg/kg/day). Conclusion. An uncommon, severe complication of primary Sjogren's syndrome is acute uveitis. Combination immunosuppressive therapy may be needed to control this condition.
引用
收藏
页码:560 / 563
页数:4
相关论文
共 11 条